Presentation TCT 2019 Balancing Efficacy and Safety in Trial Interpretation Presenter: David Cohen September 27, 2019
Presentation TCT 2019 Drug-Coated Balloons in the Periphery: Red Alert or Red Herring? Presenter: Eric Secemsky September 27, 2019
News Conference News TCT 2019 Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint Todd Neale September 27, 2019
Presentation TCT 2019 When the Primary Endpoint Is Missed: The CABANA Case Study Presenter: Bernard Gersh September 27, 2019
Presentation TCT 2019 Alternatives to Intention to Treat Analysis: Can They Be Trusted? Presenter: Stuart Pocock September 27, 2019
Presentation TCT 2019 Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials Presenter: Tamim Nazif September 27, 2019
Presentation TCT 2019 Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome Presenter: Piotr Buszman September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
Presentation TCT 2019 The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial Presenter: Mark Reisman September 27, 2019
Presentation TCT 2019 PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data Presenter: Sripal Bangalore September 27, 2019
Presentation TCT 2019 PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal Presenter: Fabian Nietlispach September 27, 2019
Presentation TCT 2019 Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated? Presenter: Davide Capodanno September 27, 2019
Presentation TCT 2019 Insights into the PRECISE Randomized Clinical Trial Presenter: Sreekanth Vemulapalli September 26, 2019
Presentation TCT 2019 Case Presentation, Evolving Technology, and Clinical Trial Status Presenter: Torsten Vahl September 26, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
Presentation TCT 2019 Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices Presenter: Brian Whisenant September 26, 2019
Presentation TCT 2019 Experience on the Early Feasibility Study (US Industry’s View) Presenter: Robert Thatcher September 26, 2019
Presentation TCT 2019 Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial! Presenter: Patrick McCarthy September 26, 2019
Presentation TCT 2019 Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates Presenter: Nicolas van Mieghem September 26, 2019
Presentation TCT 2019 Making the Case for… - Rationale and Trial Updates Presenter: Philippe Genereux September 26, 2019